Testing effectiveness (Phase 2)Ended earlyNCT04129151What this trial is testingPalbociclib + Ganitumab In Ewing SarcomaWho this might be right forEwing SarcomaEwing's Sarcoma Recurrent Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Ended earlyNCT00058461What this trial is testingCombination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forB-cell Childhood Acute Lymphoblastic LeukemiaChildhood Burkitt LymphomaChildhood Diffuse Large Cell Lymphoma+6 more National Cancer Institute (NCI) 82
Early research (Phase 1)Study completedNCT00002750What this trial is testingMelphalan in Patients With Neoplastic MeningitisWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more Duke University 6
Early research (Phase 1)Study completedNCT00004232What this trial is testingBone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Northwestern University
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00994500What this trial is testingVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germ Cell Tumor+32 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00002738What this trial is testingCombination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphomaSarcoma Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT00898872What this trial is testingSWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical TrialWho this might be right forLymphoma SWOG Cancer Research Network 32
Early research (Phase 1)Study completedNCT00889408What this trial is testingDT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or LymphomaWho this might be right forLeukemiaLymphoma Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT00003110What this trial is testingBleomycin in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Case Comprehensive Cancer Center 5
Early research (Phase 1)Study completedNCT00003243What this trial is testingCombination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830667What this trial is testingCBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to TreatWho this might be right forRecurrent Childhood Ewing SarcomaRecurrent Childhood Malignant Solid NeoplasmRecurrent Childhood Rhabdomyosarcoma+9 more Children's Oncology Group 79
Early research (Phase 1)Study completedNCT00003022What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00055939What this trial is testingExatecan Mesylate in Treating Children With Relapsed or Refractory RhabdomyosarcomaWho this might be right forSarcoma Daiichi Sankyo
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Early research (Phase 1)WithdrawnNCT00886496What this trial is testingRecombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+4 more Enzon Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT00025103What this trial is testingChemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyWho this might be right forKidney Cancer Children's Cancer and Leukaemia Group 75
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30